Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Out-licensing drugs to enhance access in developing countries

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Out-licensing drugs to enhance access in developing countries. Pharmacoecon. Outcomes News 398, 4 (2003). https://doi.org/10.1007/BF03275787

    Download citation

    Keywords

    • Pharmaceutical Market
    • Consensus Approach
    • Local Presence
    • Patent Holder
    • Brandname Drug